Literature DB >> 669568

Stability and the biological activity of eel calcitonin in rats.

M Otani, S Kitazawa, H Yamauchi, T Meguro, H Orimo.   

Abstract

Hypocalcemic effect in rats of eel calcitonin was more persistent that that of porcine calcitonin and it was as persistent as that of salmon calcitonin I. Eel calcitonin was more stable than porcine or salmon calcitonin I when incubated in vitro with rat or human serum. Incubation in vitro with rat kidney or liver extract for 1 hour at 37 degrees C caused an almost complete inactivation of porcine calcitonin. On the other hand, both eel and salmon calcitonin I were inactivated less markedly and in the similar manner. The relationship between the hypocalcemic effect of calcitonins and the inactivation is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 669568     DOI: 10.1055/s-0028-1093447

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  4 in total

1.  Chemo-enzymatic synthesis and structure-activity study of artificially N-glycosylated eel calcitonin derivatives with a complex type oligosaccharide.

Authors:  Katsuji Haneda; Mizuka Tagashira; Eiichi Yoshino; Midori Takeuchi; Toshiyuki Inazu; Kazunori Toma; Hideki Iijima; Yukihiro Isogai; Masayuki Hori; Shinji Takamatsu; Yasuhisa Fujibayashi; Kazuo Kobayashi; Makoto Takeuchi; Kenji Yamamoto
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

2.  Inhibition of restraint stress by systemic (Asu1,7) eel-calcitonin.

Authors:  G Clementi; A Prato; E Rapisarda; G Conforto; O Mangano; A Caruso; U Scapagnini
Journal:  J Endocrinol Invest       Date:  1985-12       Impact factor: 4.256

3.  Effect of carbohydrate structure on biological activity of artificially N-glycosylated eel calcitonin.

Authors:  M Tagashira; A Tanaka; K Hisatani; Y Isogai; M Hori; S Takamatsu; Y Fujibayashi; K Yamamoto; K Haneda; T Inazu; K Toma
Journal:  Glycoconj J       Date:  2001-06       Impact factor: 2.916

4.  Accelerators of osteogenesis by recombinant human bone morphogenetic protein-2.

Authors:  Yasunori Okubo; Kenji Kusumoto; Kazuhisa Bessho
Journal:  Drug Target Insights       Date:  2007-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.